InvestorsHub Logo
Followers 78
Posts 24618
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 03/07/2024 8:29:14 AM

Thursday, March 07, 2024 8:29:14 AM

Post# of 27534
MNMD - 5.94 Pre-market at 7.30/7.31

MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.